Kerendia

Medicinal product

(Invented) name

Kerendia

Active substance (s)

Finerenonas

Strength

10 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

C03DA05, finerenone

Marketing authorisation holder

Bayer AG, Vokietija

Date of authorisation

2022-02-16

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Film-coated tablet	1 vnt.
Finerenonas	10 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
108166	94270	1094270	lizdinė plokštelė	N14		Receptinis	EU/1/21/1616/001	Netiekiama	-	-	No	-	-
108167	94271	1094271	lizdinė plokštelė	N28		Receptinis	EU/1/21/1616/002	Tiekiama	-	-	No	-	-
108168	94272	1094272	lizdinė plokštelė	N98		Receptinis	EU/1/21/1616/003	Netiekiama	-	-	No	-	-
108169	94273	1094273	dalomoji lizdinė plokštelė	N100×1		Receptinis	EU/1/21/1616/004	Netiekiama	-	-	No	-	-
108170	94274	1094274	buteliukas	N100		Receptinis	EU/1/21/1616/005	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2022-02-16	Registruotas